dapi 28718-90-3 (neoFroxx Inc)
90
Structured Review
neoFroxx Inc
dapi 28718-90-3
Dapi 28718 90 3, supplied by neoFroxx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dapi+28718-90-3/dapi+28718+90+3/pm38704915-112-48-49
Average 90 stars, based on 1 article reviews
Dapi 28718 90 3, supplied by neoFroxx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dapi+28718-90-3/dapi+28718+90+3/pm38704915-112-48-49
Average 90 stars, based on 1 article reviews
dapi 28718-90-3 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Incubation:Article Title: The EPRS-ATF4-COLI pathway axis is a potential target for anaplastic thyroid carcinoma therapy. Article Snippet: Background: Anaplastic thyroid carcinoma (ATC) is recognized as the most aggressive and malignant form of thyroid cancer, underscoring the critical need for effective therapeutic strategies to curb its progression and improve patient prognosis.. Halofuginone (HF), a derivative of febrifugine, has displayed antitumor properties across various cancer types.. However, there is a paucity of published research focused on the potential of HF to enhance the clinical efficacy of treating ATC. Staining:Article Title: The EPRS-ATF4-COLI pathway axis is a potential target for anaplastic thyroid carcinoma therapy. Article Snippet: Background: Anaplastic thyroid carcinoma (ATC) is recognized as the most aggressive and malignant form of thyroid cancer, underscoring the critical need for effective therapeutic strategies to curb its progression and improve patient prognosis.. Halofuginone (HF), a derivative of febrifugine, has displayed antitumor properties across various cancer types.. However, there is a paucity of published research focused on the potential of HF to enhance the clinical efficacy of treating ATC. |